133 related articles for article (PubMed ID: 11444374)
1. Unusual DNA binding exhibited by synthetic distamycin analogues lacking the N-terminal amide unit under high salt conditions.
Thomas M; Rao AR; Varshney U; Bhattacharya S
J Biomol Struct Dyn; 2001 Jun; 18(6):858-71. PubMed ID: 11444374
[TBL] [Abstract][Full Text] [Related]
2. GC base sequence recognition by oligo(imidazolecarboxamide) and C-terminus-modified analogues of distamycin deduced from circular dichroism, proton nuclear magnetic resonance, and methidiumpropylethylenediaminetetraacetate-iron(II) footprinting studies.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Biochemistry; 1993 Apr; 32(16):4237-45. PubMed ID: 8476851
[TBL] [Abstract][Full Text] [Related]
3. Binding of nonintercalative antitumor drugs to DNA-polymers: structural effects of bisquaternary ammonium heterocycles.
Burckhardt G; Zimmer C; Baguley B
J Biomol Struct Dyn; 1987 Apr; 4(5):813-31. PubMed ID: 2855923
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
5. DNA-binding properties of a distamycin-ellipticine hybrid molecule.
Bailly C; O'Huigin C; Houssin R; Colson P; Houssier C; Rivalle C; Bisagni E; Henichart JP; Waring MJ
Mol Pharmacol; 1992 May; 41(5):845-55. PubMed ID: 1588919
[TBL] [Abstract][Full Text] [Related]
6. The binding of nonintercalative drugs to alternating DNA sequences.
Gago F; Reynolds CA; Richards WG
Mol Pharmacol; 1989 Feb; 35(2):232-41. PubMed ID: 2465487
[TBL] [Abstract][Full Text] [Related]
7. DNA binding of the nonintercalative ligands SN-6132, SN-6131 and SN-6113: minor variations of the ligand structure may cause changes in the base pair preference.
Luck G; Störl J; Baguley B; Zimmer C
J Biomol Struct Dyn; 1992 Dec; 10(3):551-64. PubMed ID: 1492924
[TBL] [Abstract][Full Text] [Related]
8. Two binding modes of netropsin are involved in the complex formation with poly(dA-dT).poly(dA-dT) and other alternating DNA duplex polymers.
Burckhardt G; Votavova H; Sponar J; Luck G; Zimmer C
J Biomol Struct Dyn; 1985 Feb; 2(4):721-36. PubMed ID: 2856018
[TBL] [Abstract][Full Text] [Related]
9. Design of distamicin analogues to probe the physical origin of the antiparallel side by side oligopeptide binding motif in DNA minor groove recognition.
Chen YH; Yang Y; Lown JW
Biochem Biophys Res Commun; 1996 Mar; 220(1):213-8. PubMed ID: 8602847
[TBL] [Abstract][Full Text] [Related]
10. Interaction of synthetic analogues of distamycin with poly(dA-dT): role of the conjugated N-methylpyrrole system.
Dasgupta D; Parrack P; Sasisekharan V
Biochemistry; 1987 Oct; 26(20):6381-6. PubMed ID: 3427012
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition between ligands and nucleic acids: DNA binding characteristics of analogues of Hoechst 33258 designed to exhibit altered base and sequence recognition.
Rao KE; Lown JW
Chem Res Toxicol; 1991; 4(6):661-9. PubMed ID: 1725495
[TBL] [Abstract][Full Text] [Related]
12. Interaction of synthetic analogs of distamycin with DNA. Role of the conjugated N-methylpyrrole system in specificity of binding.
Parrack P; Dasgupta D; Ayyer J; Sasisekharan V
FEBS Lett; 1987 Feb; 212(2):297-301. PubMed ID: 3817162
[TBL] [Abstract][Full Text] [Related]
13. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
Bailly C; Hénichart JP; Colson P; Houssier C
J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
[TBL] [Abstract][Full Text] [Related]
14. [Reaction of fluorescent labeled analogs of the antibiotic distamycin A with synthetic polydeoxyribonucleotides].
Krylov AS; Grokhovskiĭ SL; Zasedatelev AS; Zhuze AL; Gurskiĭ GV
Biofizika; 1979; 24(1):181-8. PubMed ID: 435536
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, DNA binding and antiviral activity of distamycin analogues containing different heterocyclic moieties.
Arcamone F; Lazzari E; Menozzi M; Soranzo C; Verini MA
Anticancer Drug Des; 1986 Nov; 1(3):235-44. PubMed ID: 3450296
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding of YO to [poly(dA-dT)]2 and [poly(dG-dC)]2, and of the fluorescent properties of YO and YOYO complexed with the polynucleotides and double-stranded DNA.
Larsson A; Carlsson C; Jonsson M
Biopolymers; 1995 Aug; 36(2):153-67. PubMed ID: 7492743
[TBL] [Abstract][Full Text] [Related]
17. Interactions of intercalative and minor groove binding ligands with triplex poly(dA).[poly(dT)]2 and with duplex poly(dA).poly(dT) and poly[d(A-T)]2 studied by CD, LD, and normal absorption.
Kim HK; Kim JM; Kim SK; Rodger A; Nordén B
Biochemistry; 1996 Jan; 35(4):1187-94. PubMed ID: 8573573
[TBL] [Abstract][Full Text] [Related]
18. Pyrazole analogues of the bispyrrolecarboxamide anti-tumour antibiotics: synthesis, DNA binding and anti-tumour properties.
Lee HH; Boyd M; Gravatt GL; Denny WA
Anticancer Drug Des; 1991 Nov; 6(5):501-17. PubMed ID: 1662514
[TBL] [Abstract][Full Text] [Related]
19. Interaction specificity of benzimidazol group compounds with AT-containing polynucleotides.
Akimenko NM; Garabadgiu AV; Skuratovskii IYa ; Sagi J; Szabolcs A; Ebinger K
J Biomol Struct Dyn; 1995 Apr; 12(5):1121-7. PubMed ID: 7626244
[TBL] [Abstract][Full Text] [Related]
20. Amide isosteres of lexitropsins: synthesis, DNA binding characteristics and sequence selectivity of thioformyldistamycin.
Zimmermann J; Rao KE; Joseph T; Sapse AM; Lown JW
J Biomol Struct Dyn; 1991 Dec; 9(3):599-611. PubMed ID: 1815646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
